Planning for the Best

Tripartite National Strategic Plan for Radiation Oncology 2012-2022


  1. Australian Bureau of Statistics (“The Causes of Death in Australia 2008”). Leading causes of Death in Australia. [Internet]. 2011 [cited 2012May 7]. Available from
  2. Thrall, JH. Building Research Programs in Diagnostic Radiology Part III. Clinical and Translational Research. Radiology 2007; 243:5–9.Available from: [Cited 2012 May 7]
  3. Sarin K. Clinical Trials: Overview and Opportunities [Internet]. Available from [Cited 2012 May 7]
  4. U.S. National Institutes of Health. Understanding Clinical Trials. What are the phases of clinical trials? [Internet]. 2007 [updated 2007 Sept 20; cited 2012 May 10] Available from:
  5. NHMRC funded research into cancer and other malignant neoplasms 2000 – 2011. [Internet].2012 [page reviewed 2012 Feb 6; cited 2012 Apr 6]. Available from:
  6. Information emailed to RANZCR by Sam Thorp | Research Communication and Community Engagement Officer, Cancer Council NSW.
  7. Delaney G, Jacobs S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment Estimating optimal utilization from a review of evidence-based clinical guidelines. Wiley Online Library. 3 AUG 2005 [cited 2012 May 7]. Available from:
  8. SBU – The Swedish Council on Technology Assessment in Health Care. Radiotherapy for cancer. Acta Oncologica 1996; 35 (Suppl 6)
  9. The NIH Common fund office of the strategic coordination. Translational research. [Internet].2011 [updated 2011 Jan 01; cited 2012 Apr 12]. Available from:
  10. The University of Sydney. Current national competitive grants. [Internet].2010 [updated 2010 Nov 15; cited 2012 Apr 11]. Available from:
  11. Constantin D E, Fahrig R, Keall P J. A study of the effect of in-line and perpendicular magnetic fields on beam characteristics of electron guns in medical linear accelerators. Med Phys. 2011 Jun; 38 (7): 4174-85
  12. Thorwarth D, Geets X, Paiusco M. Physical radiotherapy treatment planning based on functional PET/CT data Radiotherapy and Oncology 2010; 96(3): 317-24
  13. Thorwarth D, Alber M: Implementation of hypoxia imaging into treatment planning and delivery Radiotherapy and Oncology 2010; 97(2): 172-5
  14. Li XA, Semenenko VA, Alber M et al: The use and QA of biologically related models for treatment planning: Short report of the TG-166 of the therapy physics committee of the AAPM , Med. Phys. 2012;39, 1386
  15. B Hårdemark, Liander A, Rehbinder H, Loef J, Robinson D. P3IMRT. Biological optimization and EUD. Philips White Paper No. 4535 983 02482 (2004)
  16. B. Sanchez-Nieto and A. E. Nahum, BIOPLAN: Software for the biological evaluation of radiotherapy treatment plans. Med. Dosim. 2000; 25, 71–76
  17. Islam M K, Purdie TG, Norrlinger BD, Alasti H et al. Patient dose from kilovoltage cone beam computed tomography imaging in radiation therapy. Med Phys. 2006 Jun ;33 (6):1573-82
  18. Létourneau D, Wong JW, Oldham M, Gulam M et al. Cone-beam-CT guided radiation therapy: technical implementation. Radiotherapy and Oncology. 2005 Jun; 75 (3): 279-86
  19. TROG Cancer Research. Open Trials: 10.01 A Multi-centre Feasibility Study of Online Adaptive Image Guided Radiotherapy for Muscle Invasive Bladder Cancer “BOLART” Available from:
  20. Keall P J, Sawant A, Cho B, Ruan D et al. Electromagnetic-Guided Dynamic Multileaf Collimator Tracking Enables Motion Management for Intensity-Modulated Arc Therapy. International Journal of Radiation Oncology, Biology, Physics. 2011 Jan; 79 (1): 312-20
  21. Arancini WD, Brackenridge SA. Tin foil modified electron radiation of the skin of the nose. The Radiographer 2008; 55 (1): 7–11
  22. http:/ Cancer Institute NSW. Translational Research Program. [Internet] 2012 [updated 2012 Jan 20; cited 2012 Apr 7]. Available from:
  23. Written submission from Cancer Australia
  24. Glimelius B, Ask A, Bjelkengren G, Björk-Eriksson T et al. Number of patients potentially eligible for proton therapy. Acta Oncol. 2005;44:836–49, 200549
  25. Glimelius B, Montelius A. Proton beam therapy – Do we need the randomized trials and can we do them? Radiotherapy and Oncology. 2007; 83:105–109
  26. Lodge M, Pijls-Johannesma M, Stirk L, Munro A, De Ruysscher D, Jefferson T, A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer Radiotherapy and Oncology. 2007; 83: 110–122
  27. Olsen DR, Bruland OS, Frykholm G, Norderhaug IN. Proton therapy – a systematic review of clinical effectiveness. Radiotherapy & Oncology.2007; 83(2):123-132. Available from:
  28. Submission to the McKeon Review: Clinical cancer research. COSA & CCA Joint submission to the Strategic Review of Health and Medical Research in Australia Clinical Oncological Society of Australia and Cancer Council Australia Clinical Cancer Research. [Internet]. Available from: